IL6 and cancer: Cancer cells eliminate cancer antigens and escape recognition from immune cells through the expression of immune checkpoint molecules such as PD-L1, and produce various immunosuppressive factors such as TGF-β, IL-6, and VEGF to suppress the activation of immune cells such as DCs, macrophages, and T cells [9, 10].